July 21, 2022
GREENWICH, CT and ISELIN, NJ – Today Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the health care industry, announced a growth investment and partnership with Ephicacy Consulting Group, Inc., (“Ephicacy”), a leading biometrics Contract Research Organization (“CRO”) with operations in the United States, Canada, and India. The Company was founded in 2005 by Ganesh Gopal, its Chief Executive Officer. Ephicacy provides statistical programming, data management, and real-world evidence (“RWE”) analytics services to pharmaceutical and biotechnology companies around the world.
“Ephicacy has differentiated itself as a global leader in clinical analytics. Sophisticated data analysis is critical to clinical trial and regulatory success and pharma companies rely on specialized CROs like Ephicacy for outsourced biostatistics support,” said Rohan Saikia, Managing Director at Great Point Partners. “Ephicacy has been growing rapidly, and we are excited to partner with Ganesh and the rest of the team to accelerate growth.”
“Great Point’s expertise and investment success in the pharmaceutical services space was clearly evident when they first approached us about a partnership,” said Ganesh Gopal, CEO of Ephicacy. “s Partnering with GPP which has a strong track record and deep health care network, will enable us to accelerate our growth as a high-quality clinical analytics services partner to our pharmaceutical and biotechnology clients.”
About Great Point Partners
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP III. Great Point manages $1.5B of capital (including GPP IV which has been closed but not been activated) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 200 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.
About Ephicacy Consulting Group, Inc.
Headquartered in Iselin, NJ, with employees and operations across North America and India, Ephicacy is a rapidly growing biometrics CRO, providing outsourced statistical programming, data management, and real-world evidence (“RWE”) analytics services to pharmaceutical and biotechnology companies, primarily under a Functional Service Provider (“FSP”) model. Since its founding in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool of over 350 resources to help global pharmaceutical and biotechnology companies reduce their time to market in a cost-effective manner. More information on the Company and its services can be viewed online at www.ephicacy.com